27.78
전일 마감가:
$27.65
열려 있는:
$27.56
하루 거래량:
240.60K
Relative Volume:
0.65
시가총액:
$863.38M
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
23.34
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
+3.39%
1개월 성능:
-1.28%
6개월 성능:
-16.88%
1년 성능:
-25.94%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
COLL
Collegium Pharmaceutical Inc
|
27.78 | 863.38M | 566.77M | 48.16M | 274.29M | 1.19 |
![]()
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 업그레이드 | Needham | Hold → Buy |
2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
2023-08-25 | 재확인 | Needham | Buy |
2023-05-02 | 재개 | Jefferies | Buy |
2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | 재확인 | H.C. Wainwright | Buy |
2020-07-14 | 개시 | BWS Financial | Sell |
2020-05-27 | 개시 | Guggenheim | Neutral |
2020-02-19 | 재개 | Jefferies | Buy |
2019-10-30 | 재확인 | Needham | Buy |
2019-05-03 | 재개 | H.C. Wainwright | Buy |
2019-04-12 | 재개 | Janney | Buy |
2019-03-20 | 개시 | SunTrust | Hold |
2019-01-16 | 재확인 | Needham | Buy |
2018-03-08 | 재확인 | H.C. Wainwright | Buy |
2018-02-07 | 재확인 | Needham | Buy |
2017-12-05 | 재확인 | Needham | Buy |
2017-09-11 | 개시 | H.C. Wainwright | Buy |
2017-05-11 | 재확인 | Needham | Buy |
2016-09-13 | 개시 | Gabelli & Co | Buy |
2015-06-01 | 개시 | Jefferies | Buy |
2015-06-01 | 개시 | Needham | Buy |
2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
BlackRock, Inc. Reduces Stake in Collegium Pharmaceutical Inc. - GuruFocus
Wells Fargo & Company MN Sells 9,987 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Collegium Pharmaceutical (COLL) Projected to Post Earnings on Thursday - Defense World
Raymond James Financial Inc. Invests $2.43 Million in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Price Target at $43.60 - Defense World
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewswire
Collegium Pharmaceutical Q1 2025 Earnings Date Revealed: Key Financial Results Coming May 8 - Stock Titan
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Russell Investments Group Ltd. Trims Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Federated Hermes Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to “Buy” at StockNews.com - Defense World
Geode Capital Management LLC Sells 5,098 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Alliancebernstein L.P. Sells 66,120 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by LPL Financial LLC - Defense World
Trading (COLL) With Integrated Risk Controls - news.stocktradersdaily.com
Collegium Appoints Nancy S. Lurker to its Board of Directors - The Globe and Mail
2 Reasons to Watch COLL and 1 to Stay Cautious - Yahoo Finance
2 Reasons To Watch COLL And 1 To Stay Cautious - Barchart.com
Wellington Management Group LLP Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
StockNews.com Upgrades Collegium Pharmaceutical (NASDAQ:COLL) to “Strong-Buy” - Defense World
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Earns “Buy” Rating from Needham & Company LLC - Defense World
Sei Investments Co. Has $294,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
What Analysts Are Saying About Collegium Pharmaceutical Stock - Benzinga
Corebridge Financial Inc. Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Position Cut by American Century Companies Inc. - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 52-Week Low – Time to Sell? - Defense World
Prudential Financial Inc. Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Has Caught The Eye Of Investors - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Thrivent Financial for Lutherans - Defense World
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? - Yahoo Finance
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - Yahoo Finance
Teacher Retirement System of Texas Has $274,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):